dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | de Braud, Filippo G. |
dc.contributor.author | Maur, Michela |
dc.contributor.author | Loong, Herbert H. |
dc.contributor.author | Shaw, Alice Tsang |
dc.contributor.author | Vansteenkiste, Johan F. |
dc.date.accessioned | 2021-11-04T07:05:11Z |
dc.date.available | 2021-11-04T07:05:11Z |
dc.date.issued | 2020-03 |
dc.identifier.citation | Felip E, de Braud FG, Maur M, Loong HH, Shaw AT, Vansteenkiste JF, et al. Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study. J Thorac Oncol. 2020 Mar;15(3):392–403. |
dc.identifier.issn | 1556-1380 |
dc.identifier.uri | https://hdl.handle.net/11351/6494 |
dc.description | Ceritinib; NSCLC, Nivolumab |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Journal of Thoracic Oncology;15(3) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Quimioteràpia |
dc.subject | Quimioteràpia combinada |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.title | Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.jtho.2019.10.006 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1016/j.jtho.2019.10.006 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [de Braud FG] University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. [Maur M] AOU Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy. [Loong HH] The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. [Shaw AT] Massachusetts General Hospital, Boston, Massachusetts. [Vansteenkiste JF] University Hospital KU Leuven, Leuven, Belgium |
dc.identifier.pmid | 31634667 |
dc.identifier.wos | 000516801100020 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |